NFKB1 and autoimmune disease: Given the ubiquitous nature of the NF-κB signaling pathway and its involvement in the regulation of hundreds of target genes, RelA deficiency may also present with autoimmune diseases owing to its potential impact on inflammatory responses, autoimmunity, and carcinogenesis (17).